Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 182

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia

Open access
Talos, Delia M., Sun, Hongyu, Kosaras, Bela, Joseph, Annelise, Folkerth, Rebecca D., Poduri, Annapurna, Madsen, Joseph R., Black, Peter M., Jensen, Frances E.·2012·Annals of Neurology

Abstract

Objective: The most common neurological symptom of tuberous sclerosis complex (TSC) and focal cortical dysplasia (FCD) is early life refractory epilepsy. As previous studies have shown enhanced excitatory glutamatergic neurotransmission in TSC and FCD brains, we hypothesized that neurons associated with these lesions may also express altered γ‐aminobutyric acid (GABA) A receptor (GABA A R)‐mediated inhibition. Methods: Expression of the GABA A R subunits α1 and α4, and the Na + ‐K + ‐2Cl − (NKCC1) and the K + ‐Cl − (KCC2) transporters, in human TSC and FCD type II specimens were analyzed by Western blot and double label immunocytochemistry. GABA A R responses in dysplastic neurons from a single case of TSC were measured by perforated patch recording and compared to normal‐appearing cortical neurons from a non‐TSC epilepsy case. Results: TSC and FCD type IIb lesions demonstrated decreased expression of GABA A R α1, and increased NKCC1 and decreased KCC2 levels. In contrast, FCD type IIa lesions showed decreased α4, and increased expression of both NKCC1 and KCC2 transporters. Patch clamp recordings from dysplastic neurons in acute slices from TSC tubers demonstrated excitatory GABA A R responses that were significantly attenuated by the NKCC1 inhibitor bumetanide, in contrast to hyperpolarizing GABA A R‐mediated currents in normal neurons from non‐TSC cortical slices. Interpretation: Expression and function of GABA A Rs in TSC and FCD type IIb suggest the relative benzodiazepine insensitivity and more excitatory action of GABA compared to FCD type IIa. These factors may contribute to resistance of seizure activity to anticonvulsants that increase GABAergic function, and may justify add‐on trials of the NKCC1 inhibitor bumetanide for the treatment of TSC and FCD type IIb‐related epilepsy. ANN NEUROL 2012

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.22696

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 182

Metadata

Authors
Talos, D. M., Sun, H., Kosaras, B., Joseph, A., Folkerth, R. D., Poduri, A., Madsen, J. R., Black, P. M., & Jensen, F. E.
Venue
Annals of Neurology
Publisher
Wiley
Published
2012-03-23
Volume
71
Issue
4
Pages
539-551
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2103738596
Cited by
182
References
5
FWCI
5.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. https://app.cochat.ai/papers/10.1002/ana.22696
The paper
Talos, D. M., Sun, H., Kosaras, B., Joseph, A., Folkerth, R. D., Poduri, A., Madsen, J. R., Black, P. M., & Jensen, F. E. (2012). Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Annals of Neurology. https://doi.org/10.1002/ana.22696

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.